SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Ingredients News

How to get the most out of CPhI - a survival guide for pharma's biggest tradeshow

03-Oct-2016 - CPhI Worldwide is a marathon not a sprint says marketing guru Raman Sehgal who has written a survival guide for folks going to the drug industry’s biggest tradeshow.

AbbVie API plant opens in Singapore as first part of larger $320m site

29-Sep-2016 - AbbVie has opened an oncology and women’s health API plant, part of its planned 120,000m2 small and large molecule manufacturing site in Singapore.

US FDA: Cheng Fong Chemical must do more to investigate complaints

28-Sep-2016 - Cheng Fong Chemical has addressed problems at its Taoyuan City plant but still needs to identify the source of foreign matter found in its APIs according to the US FDA.

Moody's maintains B1 rating of merger-bound Avantor

27-Sep-2016 - Avantor Performance Materials has had its positive rating reiterated by Moody’s just days before its merger with Nusil Technology is expected to complete.

BASF set to start making PVP in China

27-Sep-2016 - BASF is poised to start making polyvinylpyrrolidone (PVP) at its facility in Shanghai, China after completing work on a $70m (€62m) manufacturing expansion.

Cambrex bolstering API services through $25m PharmaCore acquisition

26-Sep-2016 - Cambrex will acquire clinical-scale API maker PharmaCore for $25m adding a standalone GMP facility in North Carolina approved to make Schedule II to V products.

DSP: Pharmas must be open about API suppliers to fight antibiotic resistance

26-Sep-2016 - Drug companies need to me more open about their API suppliers to help fight the spread of antimicrobial resistance (AMR) according to DSM Sinochem Pharmaceuticals.

Urine derived clot busters do not pose Zika risk says EMA

22-Sep-2016 - Clot busting drugs derived from human urine are no more likely to be contaminated with Zika virus than other medicines according to research by the EMA.

US FDA warns API firm Hebei Yuxing Bio-Engineering

21-Sep-2016 - Banned API firm Hebei Yuxing Bio-Engineering has had a microbial contamination problem at its plant since 2013 according to the US FDA.

Johnson Matthey's refurbished Annan API plant passes MHRA GMP inspection

20-Sep-2016 - The UK MHRA has awarded Johnson Matthey’s API facility in Scotland a GMP certificate.

Indoco Remedies stresses that Form 483s are not data integrity related

14-Sep-2016 - Indoco Remedies says problems the US FDA identified at an ophthalmic and injectable drug plant in Goa, India last month are “correctable.”

Cambrex investment continues as industry trends ‘remain favorable’

07-Sep-2016 - The latest in a series of investments, Cambrex has recently expanded its Sweden-based site as part of its ongoing investment in small molecule API manufacturing across its global network of facilities. 

AMRI expects to make layoffs during Euticals integration

07-Sep-2016 - AMRI has said integrating recent Italian acquisition Prime European Therapeuticals, also known as Euticals, will involve layoffs.

Avara to buy ex Crestor API plant from AstraZeneca

07-Sep-2016 - Avara Pharmaceutical Services will buy the UK manufacturing facility at which AstraZeneca made the API for Crestor and Seroquel.

More Cambrex capacity expansion: API firm to grow Karlskoga facility

07-Sep-2016 - Cambrex will spend $9m (€8m) to add large-scale manufacturing capability at its API production facility in Karlskoga, Sweden.

IPEC China joins EXCiPACT, promoting excipient safety, quality

07-Sep-2016 - The global excipient certification organization has announced IPEC Association (China) Limited as its fifth member, joining IPEC Europe, IPEC Americas, FECC, and PQG (UK).

Chemical fast-track could speed up nitrile drug synthesis

06-Sep-2016 - A synthetic short cut could make it easier and cheaper to produce nitrile-containing compounds, a group which includes dozens of marketed and pipeline drugs.

'Chipped paint' and 'flying insects,' FDA slams two Chinese API plants

01-Sep-2016 - Xinxiang Tuoxin Biochemical has received a US FDA warning letter after manufacturing equipment at two API facilities were found to be in a state of disrepair.

News in brief

Agilent helps launch carbohydrate analysis lab

29-Aug-2016 - The University of Adelaide and Agilent Technologies Australia Pty have partnered on the analysis of complex carbohydrates (‘glycans’).

API firm Unimark Remedies warned by US FDA about Indian plants

25-Aug-2016 - The US FDA has warned API manufacturer Unimark Remedies about unsanitary conditions at its facility in Vapi and Bavla in India.

CMO contracts will transfer to Pfizer

Pfizer to buy AstraZeneca's antibiotic business in deal worth up to $1.5bn

24-Aug-2016 - Pfizer will buy most of AstraZeneca’s antibiotics business in a $1.5bn (€1.32bn) deal that will see the Anglo-Swedish drug firm continue to package Merrem at its Macclesfield, UK plant for at least the next 18 months.

Pharma pollution an 'ignored' cause of antibiotic resistance

24-Aug-2016 - Pollution in pharma supply chains is contributing to the spread of antimicrobial resistance (AMR), says a new report.

New synthesis promises to cut cost of making amine drugs

24-Aug-2016 - Scientists in Switzerland have developed a simple and cheap way to synthesise amines - compounds that form the backbone of many active pharmaceutical ingredients.

Phyton has developed a cell-based thapsigargin production method for Inspyr

23-Aug-2016 - Phyton Biotech has developed a cell based way of making thapsigargin, a cytotoxic plant extract that is being developed for the treatment of cancer by Inspyr Therapeutics.

BASF API biz boosts Siegfried in H1, but IT integration costs hit profits

22-Aug-2016 - Siegfried Holding AG has attributed a surge in API sales to the drug ingredients business it bought from BASF last year, but says that integration costs hurt profits.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...